Mark Jacobson - 12 Nov 2021 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Mark Jacobson
Issuer symbol
AXSM
Transactions as of
12 Nov 2021
Transactions value $
$0
Form type
4
Filing time
15 Nov 2021, 18:54:01 UTC
Next filing
08 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Employee Stock Option (Right to Buy) Award $0 +41.6K $0.00 41.6K 12 Nov 2021 Common Stock 41.6K $39.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will start to vest one year from November 12, 2021 and then will vest in substantially equal quarterly installments over three years such that the option will be fully vested on November 12, 2025.